Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 40 mg - citalopram tablets, usp are indicated for the treatment of depression. the efficacy of citalopram in the treatment of depression was established in 4 to 6 week; controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-iii and dsm-iii-r category of major depressive disorder (see clinical pharmacology ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the antidepressant action of citalopram tablets, usp in hospitalized depressed patients has not been adequately studied. the efficacy

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 40 mg - citalopram tablets, usp are indicated for the treatment of depression. the efficacy of citalopram in the treatment of depression was established in 4 to 6 week; controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-iii and dsm-iii-r category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the antidepressant action of citalopram tablets, usp in hospitalized depressed patients has not been adequately studied. the efficacy

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 20 mg - citalopram tablets, usp are indicated for the treatment of depression. the efficacy of citalopram in the treatment of depression was established in 4 to 6 week; controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-iii and dsm-iii-r category of major depressive disorder (see clinical pharmacology ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the antidepressant action of citalopram tablets, usp in hospitalized depressed patients has not been adequately studied. the efficacy

Australija - anglų - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - citalopram hydrobromide, quantity: 24.99 mg - tablet, film coated - excipient ingredients: magnesium stearate; macrogol 400; croscarmellose sodium; microcrystalline cellulose; hypromellose; pregelatinised maize starch; purified water; maize starch; purified talc; titanium dioxide; lactose monohydrate - treatment of major depression

Kanada - anglų - Health Canada

apotex inc - citalopram (citalopram hydrobromide) - tablet - 20mg - citalopram (citalopram hydrobromide) 20mg - selective-serotonin reuptake inhibitors

Kanada - anglų - Health Canada

apotex inc - citalopram (citalopram hydrobromide) - tablet - 40mg - citalopram (citalopram hydrobromide) 40mg - selective-serotonin reuptake inhibitors

Kanada - anglų - Health Canada

auro pharma inc - citalopram (citalopram hydrobromide) - tablet - 20mg - citalopram (citalopram hydrobromide) 20mg - selective-serotonin reuptake inhibitors

Kanada - anglų - Health Canada

auro pharma inc - citalopram (citalopram hydrobromide) - tablet - 40mg - citalopram (citalopram hydrobromide) 40mg - selective-serotonin reuptake inhibitors

Kanada - anglų - Health Canada

apotex inc - escitalopram (escitalopram oxalate) - tablet - 10mg - escitalopram (escitalopram oxalate) 10mg - selective-serotonin reuptake inhibitors

Kanada - anglų - Health Canada

apotex inc - escitalopram (escitalopram oxalate) - tablet - 20mg - escitalopram (escitalopram oxalate) 20mg - selective-serotonin reuptake inhibitors